Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19

Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, Prabhu Arunachalam, Diego Martinez Mori, Karen B. Jacobson, Hector Bonilla, Julie Parsonnet, Jason Andrews, Haley Hedlin, Lauren de la Parte, Kathleen Dantzler, Maureen Ty, Gene S Tan, Catherine A. Blish, Saki Takahashi, Isabel Rodriguez-Barraquer, Bryan Greenhouse, Atul J. Butte, Upinder Singh, Bali Pulendran, Taia T. Wang, Prasanna Jagannathan
doi: https://doi.org/10.1101/2021.08.27.21262687
Zicheng Hu
1Bakar Computational Health Sciences Institute, University of California, San Francisco
2Department of Microbiology and Immunology, University of California, San Francisco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hzc363@gmail.com
Kattria van der Ploeg
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saborni Chakraborty
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prabhu Arunachalam
4Institute for Immunity, Transplantation, and Infection, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego Martinez Mori
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen B. Jacobson
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hector Bonilla
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Parsonnet
3Department of Medicine, Stanford University
5Department of Epidemiology and Population Health, Stanford University, Stanford CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Andrews
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haley Hedlin
6Quantitative Sciences Unit, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren de la Parte
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen Dantzler
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maureen Ty
3Department of Medicine, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gene S Tan
7J. Craig Venter Institute, San Diego, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine A. Blish
3Department of Medicine, Stanford University
8Chan Zuckerberg Biohub, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saki Takahashi
9Department of Medicine, University of California, San Francisco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Rodriguez-Barraquer
9Department of Medicine, University of California, San Francisco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan Greenhouse
8Chan Zuckerberg Biohub, San Francisco, CA
9Department of Medicine, University of California, San Francisco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atul J. Butte
1Bakar Computational Health Sciences Institute, University of California, San Francisco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Upinder Singh
3Department of Medicine, Stanford University
10Department of Microbiology and Immunology, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bali Pulendran
4Institute for Immunity, Transplantation, and Infection, Stanford University, Stanford, CA, USA
10Department of Microbiology and Immunology, Stanford University
11Department of Pathology, Stanford University, Stanford CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taia T. Wang
3Department of Medicine, Stanford University
10Department of Microbiology and Immunology, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prasanna Jagannathan
3Department of Medicine, Stanford University
10Department of Microbiology and Immunology, Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hzc363@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The great majority of SARS-CoV-2 infections are mild and uncomplicated, but some individuals with initially mild COVID-19 progressively develop more severe symptoms. Furthermore, mild to moderate infections are an important contributor to ongoing transmission. There remains a critical need to identify host immune biomarkers predictive of clinical and virologic outcomes in SARS-CoV-2-infected patients. Leveraging longitudinal samples and data from a clinical trial of Peginterferon Lambda for treatment of SARS-CoV-2 infected outpatients, we used host proteomics and transcriptomics to characterize the trajectory of the immune response in COVID-19 patients within the first 2 weeks of symptom onset. We define early immune signatures, including plasma levels of RIG-I and the CCR2 ligands (MCP1, MCP2 and MCP3), associated with control of oropharyngeal viral load, the degree of symptom severity, and immune memory (including SARS-CoV-2-specific T cell responses and spike (S) protein-binding IgG levels). We found that individuals receiving BNT162b2 (Pfizer–BioNTech) vaccine had similar early immune trajectories to those observed in this natural infection cohort, including the induction of both inflammatory cytokines (e.g. MCP1) and negative immune regulators (e.g. TWEAK). Finally, we demonstrate that machine learning models using 8-10 plasma protein markers measured early within the course of infection are able to accurately predict symptom severity, T cell memory, and the antibody response post-infection.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04331899

Funding Statement

Support for the study was provided from NIH/NIAID (U01 AI150741-01S1 to ZH, ST, IRB, BG, TW, and PJ), Stanford Innovative Medicines Accelerator, and NIH/NIDA DP1DA046089. The Lambda clinical trial was funded by anonymous donors to Stanford University, and Peginterferon Lambda provided by Eiger BioPharmaceuticals. The funders had no role in data collection and analysis or the decision to publish.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Review Board of Stanford University.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The will be available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 29, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19
Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, Prabhu Arunachalam, Diego Martinez Mori, Karen B. Jacobson, Hector Bonilla, Julie Parsonnet, Jason Andrews, Haley Hedlin, Lauren de la Parte, Kathleen Dantzler, Maureen Ty, Gene S Tan, Catherine A. Blish, Saki Takahashi, Isabel Rodriguez-Barraquer, Bryan Greenhouse, Atul J. Butte, Upinder Singh, Bali Pulendran, Taia T. Wang, Prasanna Jagannathan
medRxiv 2021.08.27.21262687; doi: https://doi.org/10.1101/2021.08.27.21262687
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19
Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, Prabhu Arunachalam, Diego Martinez Mori, Karen B. Jacobson, Hector Bonilla, Julie Parsonnet, Jason Andrews, Haley Hedlin, Lauren de la Parte, Kathleen Dantzler, Maureen Ty, Gene S Tan, Catherine A. Blish, Saki Takahashi, Isabel Rodriguez-Barraquer, Bryan Greenhouse, Atul J. Butte, Upinder Singh, Bali Pulendran, Taia T. Wang, Prasanna Jagannathan
medRxiv 2021.08.27.21262687; doi: https://doi.org/10.1101/2021.08.27.21262687

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9758)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11634)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4648)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)